Savara to present at the oppenheimer rare & orphan disease virtual summit

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that savara management will be presenting at the oppenheimer rare & orphan disease virtual summit on friday, may 21, 2021 at 12:25 pm et / 9:25 am pt. interested parties can access a live audio webcast on the investors page of the savara website at www.savarapharma.com/investors/events-presentations/. please connect to the company's web
SVRA Ratings Summary
SVRA Quant Ranking